Prostate Cancer

• Diagnosis, Imaging, Screening
• General Information
• Risk Factors
• Risk Reduction
• Treatment

Prostate Cancer

Treatment

NEWS:

Adding Hormonal Therapy to Radiotherapy Improves Survival in Prostate Cancer

Brief Hormone Therapy Boosts Prostate Cancer Survival

Different Prostate Cancer Treatments Not That Different

Hot prostate

Osteoporosis a Risk in Prostate Cancer Therapy

Radiation, Drugs Help With Prostate Cancer

Salvage Radiation May Be Helpful in Recurrent Prostate Cancer

Two Drugs Found to Help in Prostate and Brain Cancers

ARTICLES:

Prostate Cancer, Which Treatment Best?

JOURNAL ARTICLES:

10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study. (J Urol)

A prospective study of the use of alternative therapies by men with localized prostate cancer. (Patient Educ Couns)

A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. (Cancer)

Active surveillance: towards a new paradigm in the management of early prostate cancer. (Lancet Oncol)

Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. (Urology)

An analysis of men with clinically localized prostate cancer who deferred definitive therapy. (J Urol)

Androgen deprivation therapy for prostate cancer: Current status and future prospects. (Prostate)

Case selection for radical prostatectomy in the UK. (Eur Urol)

Comparison of external radiation therapy vs radical prostatectomy in lymph node positive prostate cancer patients. (Prostate Cancer Prostatic Dis)

Complications of androgen deprivation therapy in men with prostate cancer. (Curr Oncol Rep)

Complications of androgen deprivation therapy: prevention and treatment. (Oncology (Huntingt))

Complications of prostate cancer treatment: spectrum of imaging findings. (Radiographics)

Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. (BJU Int)

Development of prostate cancer treatment: the good news. (Prostate)

Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? (Int J Radiat Oncol Biol Phys)

Early use of chemotherapy in conjunction with radical prostatectomy. (Clin Prostate Cancer)

Early versus late hormonal therapy for prostate cancer. (Curr Urol Rep)

Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients. (Asian J Androl)

Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells. (Urol Res)

External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence. (Prostate Cancer Prostatic Dis)

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. (J Natl Cancer Inst)

Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. (Radiother Oncol)

Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. (Mol Cancer Ther)

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. (Urology)

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. (J Clin Oncol)

Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment? (J Urol)

Immediate Versus Deferred Hormonal Treatment for Patients With Prostate Cancer Who Are Not Suitable for Curative Local Treatment: Results of the Randomized Trial SAKK 08/88. (J Clin Oncol)

Influence of androgen deprivation therapy on volume of anatomic zones of prostate in patients with prostate cancer using magnetic resonance imaging. (Urology)

Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients. (Int J Radiat Oncol Biol Phys)

Intermittent androgen deprivation therapy for prostate cancer. (Oncologist)

[Interstitial brachytherapy--a minimal invasive urological option for treatment of prostate cancer of increasing importance] (Versicherungsmedizin)

Is Neoadjuvant Hormonal Therapy before Radical Prostatectomy Indicated? (Urol Int)

Is there a role for chemotherapy in prostate cancer? (Br J Cancer)

Laparoscopic radical prostatectomy: the new gold standard? (Curr Urol Rep)

Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: Data from CaPSURE. (Int J Radiat Oncol Biol Phys)

Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: A single institutional study. (Int J Urol)

Lycopene for Prevention and Treatment of Prostate Cancer (Am J Health-Syst Pharm)

Management of androgen-independent prostate cancer. (Cancer Control)

Management of patients with hormone refractory prostate cancer. (Clin Oncol (R Coll Radiol).)

Minimally invasive radical prostatectomy. (Mayo Clin Proc)

Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. (Radiother Oncol)

Neoadjuvant and Adjuvant Chemotherapy for High-risk Localized Prostate Cancer. (Curr Treat Options Oncol)

Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer. (Urology)

Oxidative DNA damage in patients with prostate cancer and its response to treatment. (J Urol)

Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy. (BJU Int)

Proton therapy for prostate cancer: The initial Loma Linda University experience (Urol Oncol.)

PSA failure and the risk of death in prostate cancer patients treated with radiotherapy. (Int J Radiat Oncol Biol Phys)

Radical prostatectomy for carcinoma of the prostate. (Mod Pathol)

Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. (Urology)

Role of bisphosphonates in prostate cancer. (Eur Urol)

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (JAMA)

The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer. (BJU Int)

The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. (J Urol)

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity. (Int J Radiat Oncol Biol Phys)

The prostate cancer prevention trial: current status. (J Urol)

The specific role of isoflavones in reducing prostate cancer risk. (Prostate)

Three-dimensional Conformal Brachytherapy for Prostate Cancer. (Curr Urol Rep)

Tissue ablation technologies for localized prostate cancer. (Mayo Clin Proc)

What's a man to do? Treatment options for localized prostate cancer. (Can Fam Physician)

Go to the top